Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Delta-opioid agonists considered to have potential for improving PD symptoms

Oct. 22, 1998

SIB-1508Y exerts neuroprotective effects in addition to beneficial motor/cognitive actions

Oct. 22, 1998

Animal studies with KW-6002, a novel therapeutic for PD, presented at international congress

Oct. 22, 1998

Optimal dosing regimen defined for OCT in dose-finding studies

Oct. 21, 1998

Photoprotective efficacy obtained with topical application of vitamin C

Oct. 21, 1998

Linoladiol cream: a novel approach to treating acne

Oct. 21, 1998

Overview of studies on SDZ-ASM-981, a potential new gold standard in treating atopic dermatitis

Oct. 21, 1998

First clinical findings presented for Lilly/Synaptic antimigraine drug

Oct. 20, 1998

Good efficacy, tolerability reported for Almirall Prodesfarma's antimigraine candidate

Oct. 20, 1998

Clinical results cast further doubt on the role of substance P in migraine

Oct. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.